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Background. The induction characteristics of propofol 1% and 2% were compared in children
undergoing ENT surgery, in a prospective, randomized, double-blind study.
Methods. One hundred and eight children received propofol 1% (n=55) or 2% (n=53) for
induction and maintenance of anaesthesia. For induction, propofol 4 mg kg±1 was injected at a
constant rate (1200 ml h±1), supplemented with alfentanil. Intubating conditions without the
use of a neuromuscular blocking agent were scored.
Results. Pain on injection occurred in 9% and 21% of patients after propofol 1% and 2%,
respectively (P=0.09). Loss of consciousness was more rapid with propofol 2% compared with
propofol 1% (47 s vs 54 s; P=0.02). Spontaneous movements during induction occurred in 22%
and 34% (P=0.18), and intubating conditions were satisfactory in 87% and 96% (P=0.19) of
children receiving propofol 1% or 2%, respectively. There were no differences between the
two groups in respect of haemodynamic changes or adverse events.
Conclusions. For the end-points tested, propofol 1% and propofol 2% are similar for induc-
tion of anaesthesia in children undergoing minor ENT surgery.
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Rapid onset, good haemodynamic tolerance, and a short
duration of action are well-established advantages of
propofol 1% in children over 3 yr of age. However, pain
on injection1 and spontaneous movements during induction2
remain of particular concern in children. Propofol 2% has
recently been introduced into clinical practice, but no
controlled clinical trial has been conducted comparing these
two propofol concentrations in children. A potential
advantage of propofol 2% could be a faster induction, and
thus less pain on injection and a decreased incidence of
involuntary movements. The aim of this randomized study
was to compare the induction characteristics of propofol 1%
and 2% in a paediatric population undergoing short ENT
procedures.
Methods and results
After approval by our institutional ethics committee, written
informed consent was obtained from the parents of 130
children aged 3±12 yr scheduled for elective adenoidectomy
and/or adenotonsillectomy. Midazolam 0.5 mg kg±1 was
given orally as premedication and EMLAÔ cream was
applied to both hands. Children were randomly assigned to
receive either propofol 1% or 2% using the computer
software StatmateÔ (version 1.01 GraphPad Software Inc.,
San Diego, USA).
Propofol was given on a mg kg±1 h±1 basis by an infusion
pump (Medfusionâ 2010i, USA) in an absolutely blinded
manner, so that the anaesthetist was not aware of the
propofol concentration.
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After 3 min preoxygenation, alfentanil 20 mg kg±1 was
administered i.v. Before the propofol, lidocaine 0.5%, 1 ml
was injected i.v. without a tourniquet. An i.v. bolus of
propofol 4 mg kg±1 was then administered by the
Medfusionâ pump at a constant rate of 1200 ml h±1.
Tracheal intubation was performed 1 min after the end of
the bolus, without the use of any neuromuscular blocking
agent. Anaesthesia was maintained by propofol given at a
preprogrammed infusion rate of 12 mg kg±1 h±1, reduced to
9 mg kg±1 h±1 during surgery, and to 6 mg kg±1 h±1 when
awaiting haemostasis. The children's lungs were ventilated
with 60% nitrous oxide/oxygen throughout the procedure.
Pain on injection was considered present when the child
complained about it or when they withdrew their hand
during the injection. Abnormal movements were de®ned as
purposeless movements of any part of the body during or
immediately after the injection of propofol.2 The anaesthe-
sia induction sequence was video recorded for subsequent
analysis by one of the authors who was not involved in the
administration of the anaesthetic (AB). Unconsciousness
was de®ned as the absence of a reaction to verbal
stimulation (OAAS score <2). The quality of intubation
was evaluated according to a validated and widely used
score3 4 (1=excellent, 2=good, 3=unsatisfactory, 4=bad).
Side-effects and time of recovery (from the end of propofol
infusion to extubation) were recorded.
The two sets of data were analysed using the c2-test and
relative risks with 95% con®dence intervals. An unpaired
t-test with P<0.05 or a 95% con®dence interval excluding
1 was considered signi®cant.
Nine children in the propofol 1% group and eight children
in the propofol 2% group were excluded because of
agitation, failure to obtain venous access or technical
problems. Five children had laryngospasm after the injec-
tion of propofol (Table 1). These patients were intubated
with succinylcholine and removed from further study.
One hundred and eight children were analysed (propofol
1%, n=55; propofol 2%, n=53). The physical characteristics
of the children and duration of surgery were comparable
between the two groups.
There were no signi®cant differences between the two
groups for all primary end-points except that loss of
consciousness was more rapid with propofol 2% compared
with the 1% emulsion (47 s vs 54 s respectively; P=0.02).
Comment
The results of this study show that propofol 1% and 2% had
comparable induction characteristics except for time to loss
of consciousness (Table 1). This ®nding is explained by the
equivalent bolus rate (1200 ml h±1) used to infuse either
propofol 1% or 2%. Thus, infusing propofol 2% led to
administration of the induction dose in a shorter time, and to
a higher propofol concentration gradient between plasma
and the effect site. This may have facilitated the passage of
propofol into the effect compartment, thereby shortening the
exit rate constant from the central compartment.
A potential advantage of propofol 2% might have been a
lower incidence of pain on injection, but this was not
detected in this study (Table 1). However, the present study
has shown a lower incidence of pain than that previously
reported.1 A larger number of children would need to have
been studied to demonstrate any signi®cant difference
between propofol 1% and 2% in this respect. This lower
incidence of propofol-related pain may be attributable in
part to the administration of alfentanil before lidocaine and
propofol. It has been shown that opioids decrease propofol-
related pain. Furthermore, although it has been questioned,6
the speed of injection may have in¯uenced the results in the
present study5 as propofol was injected at a constant, albeit
much slower, rate than that used clinically for administra-
tion from a syringe. In order to compare the concentration
effects rather than the speed of injection, propofol was
administered during maintenance of anaesthesia at a
comparable rate in both groups in terms of mg kg±1 h±1.
Finally, the incidence of spontaneous movements following
injection of either propofol 1% or 2% was similar to that
described in the literature.2 Although it has been suggested
that these movements are of a subcortical rather than a
cortical nature,2 their cause remains unclear.
In conclusion, the present study shows that induction of
anaesthesia in children with propofol 1% or 2% provided
comparable clinical conditions. The difference observed in
the time to loss of consciousness was probably related to the
Table 1 Side-effects and anaesthetic conditions on administration of propofol 1% and 2% in children. Data are percentages (number) unless stated otherwise
Propofol 1% Propofol 2% P-value Relative risk
(95% con®dence interval)
(n=55) (n=53)
Pain on injection 9.1 (5) 20.8 (11) 0.09 0.58 (0.27±1.23)
Movement 21.8 (12) 33.9 (18) 0.18 0.73 (0.45±1.19)
Good intubation 87.3 (48) 96.2 (51) 0.19 0.69 (0.44±1.09)
Time to loss of consciousness (s) mean (SD) 54 (2.0) 47 (2.2) 0.02
Laryngospasm 1.8 (1/56) 7.0 (4/57) 0.36 0.40 (0.07±2.35)
Coughing 3.6 (2/55) 11.3 (6/53) 0.13 0.48 (0.14±1.60)
Erythema 5.4 (3/55) 15.1 (8/53) 0.10 0.51 (0.08±1.30)
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higher concentration of propofol 2% used in one group as a
single bolus for induction of anaesthesia.
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Background. I.V. rocuronium produces intense discomfort at the site of injection in
conscious patients. Four strategies to reduce or prevent this discomfort were studied.
Methods. Two hundred and ®fty adult patients, ASA I±III, were randomized into ®ve groups
of 50 patients in a blinded, prospective study. The control group received rocuronium 10 mg
alone. For the remaining four groups, rocuronium 10 mg was mixed with sodium bicarbonate
8.4% 2 ml, fentanyl 100 mg, lidocaine 2% or normal saline. The pH and osmolality of all mixtures
were measured. Patient data were analysed using ordinal logistic regression. Osmolality and pH
data were analysed using the Kruskal±Wallis test with Dunn's multiple comparison test.
Results. When compared with rocuronium alone, only the addition of saline failed to signi®-
cantly reduce the pain reported by patients. The addition of fentanyl reduced the complaint of
pain by 1.9 times (P<0.049) and the addition of lidocaine 2% reduced it by 3.6 times (P<0.0001).
Sodium bicarbonate 8.4% reduced the reporting of pain by 18.4 times (P<0.0001).
Conclusions. Sodium bicarbonate 8.4%, when added to rocuronium, markedly reduces the
experience of pain during the i.v. administration of a small dose of rocuronium.
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A variety of i.v. anaesthetic agents cause pain when
injected.1 Rocuronium, in particular, causes intense dis-
comfort at the site of injection in conscious patients.1±3
When administered in a subparalysing dose, 50±100% of
patients report discomfort.2 4 Attempts to reduce this
adverse effect have used premedication with i.v. midazo-
lam, fentanyl or lidocaine.5±7 Even after induction of
anaesthesia with propofol or pentothal, rocuronium causes
Sodium bicarbonate reduces rocuronium injection pain
Ó The Board of Management and Trustees of the British Journal of Anaesthesia 2003
